 The Phosphate Company Ltd Q2FY26 loss at Rs. 2.48 crore
The Phosphate Company Ltd Q2FY26 loss at Rs. 2.48 crore Emami Paper Mills Ltd Q2 FY2026 profit at Rs. 6.58 crores
Emami Paper Mills Ltd Q2 FY2026 profit at Rs. 6.58 crores Maruti Suzuki India Ltd Q2 FY2026 consolidated PAT slips QoQ to Rs. 3349 crores
Maruti Suzuki India Ltd Q2 FY2026 consolidated PAT slips QoQ to Rs. 3349 crores RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores
RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26
Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26 
              Sun Pharmaceutical Industries Ltd has announced that the Committee of Directors (Allotment) of the Company at its meeting held on September 04, 2006, has allotted 30,858 Equity Shares of Rs 5 each of the Company at a premium of Rs 724.30 per share upon exercise of option of conversion for 500 Zero Coupon Foreign Currency Convertible Bonds of US $1000 each (FCCB) into Equity shares of the Company by FCCB holder.
Consequently, the paid up Equity Share Capital of the Company has increased from 18,60,67,805 equity shares to 18,60,98,663 equity shares of Rs 5/- each, as of date.